Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?

A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium Chlamydia pneumoniae and human herpes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Neuroimmunology 2003-03, Vol.136 (1), p.1-8
Hauptverfasser: Swanborg, Robert H, Whittum-Hudson, Judith A, Hudson, Alan P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8
container_issue 1
container_start_page 1
container_title Journal of Neuroimmunology
container_volume 136
creator Swanborg, Robert H
Whittum-Hudson, Judith A
Hudson, Alan P
description A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of C. pneumoniae and HHV-6 in MS, and data relating to possession of the APOE ε4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease.
doi_str_mv 10.1016/S0165-5728(02)00465-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73081491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165572802004654</els_id><sourcerecordid>73081491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-744794ca815badd39372244676dbe47dc673d80b0bda7091ce410e0a69f9f8653</originalsourceid><addsrcrecordid>eNqFkc9q3DAQxkVJaLZpH6HBp9AenI7-WLJPoSxtEwjkkPYsZGncVbFlR7IXcutD9AnzJFF2l_SYywwDv2-G-T5CPlK4oEDll7tcqrJSrP4E7DOAyJN4Q1a0VqysBaNHZPWCnJB3Kf0BoBUXzVtyQplkILlake46dGhnPy6pML8xzLkFVwxLP_upxyLZHuOYfHr8-89ELNab3gwPzptiCrgMY_AGd4rNMphQbDBOmIqtj3mfLHzYjv0W3eV7ctyZPuGHQz8lv75_-7m-Km9uf1yvv96UtqIwl0oI1Qhralq1xjnecMWYEFJJ16JQzkrFXQ0ttM4oaKhFQQHByKZrulpW_JSc7_dOcbxfMM168Mli35uA-UWtONRUNPRVMNvIheI8g9UetNmGFLHTU_SDiQ-agn5OQu-S0M82a2B6l4QWWXd2OLC0A7r_qoP1GbjcA5j92HqMOlmPwaLzMSei3ehfOfEEMUSZyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18734733</pqid></control><display><type>article</type><title>Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Swanborg, Robert H ; Whittum-Hudson, Judith A ; Hudson, Alan P</creator><creatorcontrib>Swanborg, Robert H ; Whittum-Hudson, Judith A ; Hudson, Alan P</creatorcontrib><description>A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of C. pneumoniae and HHV-6 in MS, and data relating to possession of the APOE ε4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease.</description><identifier>ISSN: 0165-5728</identifier><identifier>EISSN: 1872-8421</identifier><identifier>DOI: 10.1016/S0165-5728(02)00465-4</identifier><identifier>PMID: 12620637</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Apolipoprotein E4 ; Apolipoproteins E - genetics ; Apolipoproteins E - immunology ; Chlamydia pneumoniae ; Chlamydophila Infections - complications ; Chlamydophila pneumoniae - immunology ; Chlamydophila pneumoniae - pathogenicity ; Genetic Predisposition to Disease ; Herpesvirus 6, Human - immunology ; Herpesvirus 6, Human - pathogenicity ; Human herpes virus-6 ; Humans ; Molecular Mimicry - immunology ; Multiple sclerosis ; Multiple Sclerosis - genetics ; Multiple Sclerosis - immunology ; Multiple Sclerosis - microbiology ; Oligodendroglia - immunology ; Oligodendroglia - microbiology ; Roseolovirus Infections - complications</subject><ispartof>Journal of Neuroimmunology, 2003-03, Vol.136 (1), p.1-8</ispartof><rights>2002 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-744794ca815badd39372244676dbe47dc673d80b0bda7091ce410e0a69f9f8653</citedby><cites>FETCH-LOGICAL-c510t-744794ca815badd39372244676dbe47dc673d80b0bda7091ce410e0a69f9f8653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0165-5728(02)00465-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>313,314,776,780,788,3536,27901,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12620637$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Swanborg, Robert H</creatorcontrib><creatorcontrib>Whittum-Hudson, Judith A</creatorcontrib><creatorcontrib>Hudson, Alan P</creatorcontrib><title>Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?</title><title>Journal of Neuroimmunology</title><addtitle>J Neuroimmunol</addtitle><description>A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of C. pneumoniae and HHV-6 in MS, and data relating to possession of the APOE ε4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease.</description><subject>Apolipoprotein E4</subject><subject>Apolipoproteins E - genetics</subject><subject>Apolipoproteins E - immunology</subject><subject>Chlamydia pneumoniae</subject><subject>Chlamydophila Infections - complications</subject><subject>Chlamydophila pneumoniae - immunology</subject><subject>Chlamydophila pneumoniae - pathogenicity</subject><subject>Genetic Predisposition to Disease</subject><subject>Herpesvirus 6, Human - immunology</subject><subject>Herpesvirus 6, Human - pathogenicity</subject><subject>Human herpes virus-6</subject><subject>Humans</subject><subject>Molecular Mimicry - immunology</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - genetics</subject><subject>Multiple Sclerosis - immunology</subject><subject>Multiple Sclerosis - microbiology</subject><subject>Oligodendroglia - immunology</subject><subject>Oligodendroglia - microbiology</subject><subject>Roseolovirus Infections - complications</subject><issn>0165-5728</issn><issn>1872-8421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9q3DAQxkVJaLZpH6HBp9AenI7-WLJPoSxtEwjkkPYsZGncVbFlR7IXcutD9AnzJFF2l_SYywwDv2-G-T5CPlK4oEDll7tcqrJSrP4E7DOAyJN4Q1a0VqysBaNHZPWCnJB3Kf0BoBUXzVtyQplkILlake46dGhnPy6pML8xzLkFVwxLP_upxyLZHuOYfHr8-89ELNab3gwPzptiCrgMY_AGd4rNMphQbDBOmIqtj3mfLHzYjv0W3eV7ctyZPuGHQz8lv75_-7m-Km9uf1yvv96UtqIwl0oI1Qhralq1xjnecMWYEFJJ16JQzkrFXQ0ttM4oaKhFQQHByKZrulpW_JSc7_dOcbxfMM168Mli35uA-UWtONRUNPRVMNvIheI8g9UetNmGFLHTU_SDiQ-agn5OQu-S0M82a2B6l4QWWXd2OLC0A7r_qoP1GbjcA5j92HqMOlmPwaLzMSei3ehfOfEEMUSZyg</recordid><startdate>20030301</startdate><enddate>20030301</enddate><creator>Swanborg, Robert H</creator><creator>Whittum-Hudson, Judith A</creator><creator>Hudson, Alan P</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20030301</creationdate><title>Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?</title><author>Swanborg, Robert H ; Whittum-Hudson, Judith A ; Hudson, Alan P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-744794ca815badd39372244676dbe47dc673d80b0bda7091ce410e0a69f9f8653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Apolipoprotein E4</topic><topic>Apolipoproteins E - genetics</topic><topic>Apolipoproteins E - immunology</topic><topic>Chlamydia pneumoniae</topic><topic>Chlamydophila Infections - complications</topic><topic>Chlamydophila pneumoniae - immunology</topic><topic>Chlamydophila pneumoniae - pathogenicity</topic><topic>Genetic Predisposition to Disease</topic><topic>Herpesvirus 6, Human - immunology</topic><topic>Herpesvirus 6, Human - pathogenicity</topic><topic>Human herpes virus-6</topic><topic>Humans</topic><topic>Molecular Mimicry - immunology</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - genetics</topic><topic>Multiple Sclerosis - immunology</topic><topic>Multiple Sclerosis - microbiology</topic><topic>Oligodendroglia - immunology</topic><topic>Oligodendroglia - microbiology</topic><topic>Roseolovirus Infections - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swanborg, Robert H</creatorcontrib><creatorcontrib>Whittum-Hudson, Judith A</creatorcontrib><creatorcontrib>Hudson, Alan P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Neuroimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swanborg, Robert H</au><au>Whittum-Hudson, Judith A</au><au>Hudson, Alan P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?</atitle><jtitle>Journal of Neuroimmunology</jtitle><addtitle>J Neuroimmunol</addtitle><date>2003-03-01</date><risdate>2003</risdate><volume>136</volume><issue>1</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>0165-5728</issn><eissn>1872-8421</eissn><abstract>A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of C. pneumoniae and HHV-6 in MS, and data relating to possession of the APOE ε4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>12620637</pmid><doi>10.1016/S0165-5728(02)00465-4</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-5728
ispartof Journal of Neuroimmunology, 2003-03, Vol.136 (1), p.1-8
issn 0165-5728
1872-8421
language eng
recordid cdi_proquest_miscellaneous_73081491
source MEDLINE; Elsevier ScienceDirect Journals
subjects Apolipoprotein E4
Apolipoproteins E - genetics
Apolipoproteins E - immunology
Chlamydia pneumoniae
Chlamydophila Infections - complications
Chlamydophila pneumoniae - immunology
Chlamydophila pneumoniae - pathogenicity
Genetic Predisposition to Disease
Herpesvirus 6, Human - immunology
Herpesvirus 6, Human - pathogenicity
Human herpes virus-6
Humans
Molecular Mimicry - immunology
Multiple sclerosis
Multiple Sclerosis - genetics
Multiple Sclerosis - immunology
Multiple Sclerosis - microbiology
Oligodendroglia - immunology
Oligodendroglia - microbiology
Roseolovirus Infections - complications
title Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A58%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infectious%20agents%20and%20multiple%20sclerosis%E2%80%94are%20Chlamydia%20pneumoniae%20and%20human%20herpes%20virus%206%20involved?&rft.jtitle=Journal%20of%20Neuroimmunology&rft.au=Swanborg,%20Robert%20H&rft.date=2003-03-01&rft.volume=136&rft.issue=1&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=0165-5728&rft.eissn=1872-8421&rft_id=info:doi/10.1016/S0165-5728(02)00465-4&rft_dat=%3Cproquest_cross%3E73081491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18734733&rft_id=info:pmid/12620637&rft_els_id=S0165572802004654&rfr_iscdi=true